Breast Neoplasms  >>  pegylated liposomal doxorubicin  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pegylated liposomal doxorubicin / Generic mfg.
NCT00746694: A Study to Determine the Management of Palmar-plantar Erythrodysesthesia (PPE) in Patients With Metastatic Ovarian or Breast Cancer Treated With Caelyx (Study P05020)

Completed
N/A
154
Europe
Merck Sharp & Dohme LLC
Ovarian Neoplasms, Breast Neoplasms, Paresthesia
06/09
06/09
NCT00736333: A Study to Evaluate Safety and Tolerability in Patients With Metastatic Breast Cancer Receiving Treatment With Caelyx (Study P04878)(COMPLETED)

Completed
N/A
167
Europe
Pegylated Liposomal Doxorubicin, SCH 200746
Merck Sharp & Dohme LLC
Breast Neoplasm
06/10
06/10

Download Options